| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/03/2001 | CN1278823A 1'-[4-[1-(4-Fluorophenyl)-1(H)-indole-3-yl]-1-butyl]-spiro [isobenzofuran-1(3(H),4'-piperidine] hydrohalogenides |
| 01/03/2001 | CN1278819A Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating and stress-related |
| 01/03/2001 | CN1278815A 3-oxo-2(H)-1,2,4-triazine derivativs as ligands of 5HT1A receptors |
| 01/03/2001 | CN1278810A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278800A Cyclohexane derivatives difunctionalised in 1.4 as ligands of 5T hia receptors |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278790A Chemical compound |
| 01/03/2001 | CN1278733A Viscous compositions containing carbon dioxide |
| 01/03/2001 | CN1278731A Use of mirtazapine for treating sleep apneas |
| 01/03/2001 | CN1278730A Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 01/03/2001 | CN1278729A A composition of a 5-HT reuptake inhibitor and a h5-HT 1B antagonist or partial agonist |
| 01/03/2001 | CN1278727A A combination of a monomine oxidase inhibitor and a hs-ht antagonist or partial agonist |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060060C Use of anti-anxiety medicine made from dry ginger and ginkgo |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6169116 Amino-tetralines, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/02/2001 | US6169112 Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives |
| 01/02/2001 | US6169105 Potentiating the action of paroxetine in increasing the availability of serotonin, norepinephrine and dopamine in the brain by administering paroxetine to a patient in need thereof in combination with way 100635 |
| 01/02/2001 | US6169098 Composition and methods employing it for the treatment of 5-HT-mediated disorders |
| 01/02/2001 | US6169094 Compositions of (S) (-)-amisulpride |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis |
| 01/02/2001 | US6169084 2-methyl-thieno-benzodiazepine formulation |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168805 Aqueous process for manufacturing paroxetine solid dispersions |
| 01/02/2001 | CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| 01/02/2001 | CA2174034C Novel tricyclic amides, processes for their preparation and the pharmaceutical compositions which contain them |
| 01/02/2001 | CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof |
| 01/02/2001 | CA2001572C Compositions for treating tobacco withdrawal symptoms |
| 01/02/2001 | CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues |
| 01/02/2001 | CA1341159C Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use |
| 01/01/2001 | WO2001003645A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 12/30/2000 | CA2313105A1 Treatment for diabetic complications |
| 12/30/2000 | CA2313063A1 Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors |
| 12/30/2000 | CA2312989A1 Combination therapy for the treatment of migraine |
| 12/30/2000 | CA2312633A1 Combination therapy for the treatment of migraine |
| 12/30/2000 | CA2312631A1 5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine |
| 12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
| 12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078948A2 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
| 12/28/2000 | WO2000078794A1 Cysteinyl protease inhibitors |
| 12/28/2000 | WO2000078768A1 Potassium channel openers |
| 12/28/2000 | WO2000078765A2 CHROMENO[4,3,2-de]ISOQUINOLINES AS POTENT DOPAMINE RECEPTOR LIGANDS |
| 12/28/2000 | WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 12/28/2000 | WO2000078757A1 Inhibitors of il-12 production |
| 12/28/2000 | WO2000078753A1 Process for the preparation of paroxetine and structurally related compounds |
| 12/28/2000 | WO2000078751A2 Compounds for use in treatment of neurological disorders |
| 12/28/2000 | WO2000078750A1 New pharmaceutically active compounds |
| 12/28/2000 | WO2000078746A1 Antiviral agents |
| 12/28/2000 | WO2000078744A1 Thiochroman derivatives against neurological disorders |
| 12/28/2000 | WO2000078742A1 Chroman derivatives against neurological disorders |
| 12/28/2000 | WO2000078736A1 1,4-diazacycloheptane derivatives as neuroprotective agents |
| 12/28/2000 | WO2000078730A1 Novel dihydropyrimidine derivatives |
| 12/28/2000 | WO2000078728A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 12/28/2000 | WO2000078720A1 Novel dihydropyridine derivative |
| 12/28/2000 | WO2000078719A1 Dihydropyridine derivative |
| 12/28/2000 | WO2000078718A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 12/28/2000 | WO2000078697A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | WO2000078346A1 Novel anti-allergic agents |
| 12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078331A2 Il6ril6 chimera for the treatment of neurodegenerative diseases |
| 12/28/2000 | WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 12/28/2000 | WO2000078319A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | WO2000078311A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 12/28/2000 | WO2000078304A1 V.n. vassiliev's pharmaceutical composition for restoring the sympatho-adrenal system and method for estimating the efficiency thereof |
| 12/28/2000 | WO2000078303A1 Non-malignant disease treatment with ras antagonists |
| 12/28/2000 | WO2000078296A2 Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders |
| 12/28/2000 | WO2000078291A1 Composition of paroxetine methanesulfonate |
| 12/28/2000 | WO2000078289A1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 12/28/2000 | WO2000078288A2 Novel process for paroxetine compositions |
| 12/28/2000 | WO2000056301A3 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
| 12/28/2000 | WO2000054754A3 Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000043373A3 Kinase inhibitors |
| 12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
| 12/28/2000 | WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors |
| 12/28/2000 | DE19958228A1 Paroxetinmethansulfonat enthaltendes Arzneimittel Paroxetine-containing medicines |
| 12/28/2000 | CA2377698A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
| 12/28/2000 | CA2377524A1 Novel anti-allergic agents |
| 12/28/2000 | CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | CA2376081A1 Cysteinyl protease inhibitors |
| 12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | CA2375282A1 Potassium channel openers |
| 12/28/2000 | CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions |
| 12/28/2000 | CA2375211A1 Antiviral agents |